Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
316.9 USD | +0.74% |
|
-0.66% | +44.11% |
Jul. 08 | UBS Adjusts Price Target on United Therapeutics to $370 From $300, Maintains Buy Rating | MT |
Jul. 01 | United Therapeutics Corporation(NasdaqGS:UTHR) added to Russell 1000 Defensive Index | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.11% | 14.06B | |
+17.09% | 44.63B | |
+46.00% | 40.46B | |
-9.70% | 38.07B | |
+33.28% | 32.27B | |
-8.98% | 27.3B | |
+13.37% | 26.53B | |
+32.33% | 12.54B | |
-7.26% | 11.28B | |
-14.36% | 10.43B |
- Stock Market
- Equities
- UTHR Stock
- News United Therapeutics Corporation
- Transcript : United Therapeutics Corporation Presents at JP Morgan 37th Annual Healthcare conference, Jan-07-2019 02